SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (BULLETIN BOARD: NAWL) , an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products, announced today its preliminary unaudited May 2007 sales results on a stand alone basis.
Revenue in May 2007 was $42,468 compared to $5,853 in April 2006. This represents an increase of $36,615 or 625%. For the eleven months ended May 31, 2007, NatureWell's revenue was $244,618 compared to $46,052 for the eleven months ended May 31, 2006. This represents an increase of $198,566 or approximately 431%.
"May was another good month for us," commented NatureWell, Incorporated's Chairman and Chief Executive Officer, James R. Arabia. "Right now, we pretty well know how many new healthcare practitioner accounts can be opened and how much revenue can be generated on a monthly basis by each sales representative once they have been properly trained and begin making calls. And the numbers so far make a lot of sense. So for now, the priority is on growing sales by increasing the number of sales representatives with the hope that they open new practitioner accounts at the same rate per representative that our experience demonstrates."
About NatureWell, Incorporated:
NatureWell, Incorporated (http://www.naturewell.com/) is an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products. The Company's flagship product, MigraSpray (http://www.migraspray.com/), is a patented, over-the-counter, homeopathic medicine intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the "safe harbor" provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward- looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. These and other potential risks and uncertainties are set forth in the Company's filings with the Securities & Exchange Commission. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
